Novotech

Novotech

Share

06/05/2026

Strong clinical programs start with the right foundations: access to the right sites and realistic feasibility from day one.

At Novotech, we’re taking a more integrated approach—bringing site engagement, partnerships, and feasibility together to drive better outcomes for both delivery and growth.

We’re currently looking for a Senior Director, Site Engagement & Feasibility to lead this effort within our Clinical Operations team.

This is a global role, working across Clinical, Therapeutic Strategy, Commercial, and Executive Leadership—connecting site strategy with study planning and ex*****on.

If you’ve worked in this space, you know how impactful this can be.

Apply Now: https://fa-euzi-saasfaprod1.fa.ocs.oraclecloud.com/hcmUI/CandidateExperience/en/sites/CX_1/job/3871

08/01/2026

Novotech has appointed Dr. Anand Tharmaratnam as its new Chief Executive Officer. Dr. Tharmaratnam brings nearly 30 years of experience in the global CRO industry and commenced as Chairman and CEO on 1 January 2026. He will be based at the company’s new global headquarters in Singapore. Full announcement: https://ow.ly/HW4m50XTf3T

29/12/2025

As the year draws to a close, we want to say thank you to our employees around the world, and to our clients and partners. Your hard work, trust, and collaboration are at the heart of everything we do, fundamental to our shared purpose of advancing clinical research for patients and communities worldwide. We are proud of what we have achieved together this year and deeply grateful for the relationships that make it possible.

From all of us at Novotech, we extend our best wishes for a safe and restful holiday season and continued success in the year ahead.

02/12/2025

On World AIDS Day, we recognize the researchers, clinicians, trial teams, and community partners whose work has moved HIV from crisis to chronic care and opened a clearer path toward durable remission and, one day, a cure. Modern antiretroviral therapy (ART) enables long, healthy lives and U=U (Undetectable = Untransmittable). Long-acting options are expanding choice, and cure research is advancing across antibodies, latency strategies, and gene-based approaches. Today, an estimated 40.8 million people live with HIV, and each breakthrough improves outcomes for millions.

Novotech is proud to support this progress through HIV studies across North America, Europe, and APAC, with 20 trials to date focused on inclusive design, reliable operations, and data that accelerates access.

Talk to an expert: https://ow.ly/lIy450XAs3W

Want your business to be the top-listed Engineering Company in Central Region?
Click here to claim your Sponsored Listing.

Category

Telephone

Address


Level 52, 9 Raffles Place, Republic Plaza
Central Region
048619